Cavorsi Robert bought ORGO
February 19, 2025 · Form 4 insider transaction
Cavorsi Robert bought 61,705 shares of Organogenesis Holdings Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
61,705
Price
$0.00
Total value
N/A
InsiderCavorsi Robert
Role—
SecurityClass A Common Stock
Transaction codeA: Grant or award
Transaction dateFebruary 19, 2025
Filing dateFebruary 21, 2025
Shares owned after190,463
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2025.